WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002031180) FLEA PERITROPHIN NUCLEIC ACID MOLECULES, PROTEINS AND USES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/031180    International Application No.:    PCT/US2001/031958
Publication Date: 18.04.2002 International Filing Date: 11.10.2001
Chapter 2 Demand Filed:    10.05.2002    
IPC:
A61K 39/00 (2006.01), C07K 14/435 (2006.01)
Applicants: HESKA CORPORATION [US/US]; 1613 Prospect Parkway, Fort Collins, CO 80525 (US) (For All Designated States Except US).
GAINES, Patrick, J. [US/US]; (US) (For US Only).
WISNEWSKI, Nancy [US/US]; (US) (For US Only)
Inventors: GAINES, Patrick, J.; (US).
WISNEWSKI, Nancy; (US)
Agent: VERSER, Carol, Talkington; Heska Corporation, 1613 Prospect Parkway, Fort Collins, CO 80525 (US)
Priority Data:
09/686,583 11.10.2000 US
Title (EN) FLEA PERITROPHIN NUCLEIC ACID MOLECULES, PROTEINS AND USES THEREOF
(FR) MOLECULES D'ACIDE NUCLEIQUE DE PERITROPHINE DE PUCE ET UTILISATIONS DE CELLES-CI
Abstract: front page image
(EN)The present invention relates to flea peritrophin proteins; to flea peritrophin nucleic acid molecules, including those that encode such flea peritrophin proteins; to antibodies raised against such proteins; and to compounds that inhibit the activity of such proteins. The present invention also includes methods to obtain and use such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. The present invention also includes therapeutic compositions comprising such inhibitory compounds, particularly those that specifically inhibit flea peritrophin activity, as weell as the use of such therapeutic compositions to treat animals.
(FR)L'invention concerne des protéines de péritrophine des puces et des molécules d'acide nucléique de péritrophine de puce, y compris les molécules d'acide nucléique codant pour de telles protéines de péritrophine, des anticorps dirigés contre ces protéines et des composés inhibant l'activité de ces protéines. L'invention concerne également des procédés permettant d'obtenir et d'utiliser ces protéines, molécules d'acide nucléique, anticorps et composés inhibiteurs. L'invention concerne en outre des compositions thérapeutiques comprenant de tels composés inhibiteurs, en particulier des composés qui inhibent de manière spécifique l'activité de la péritrophine de puce, ainsi que l'utilisation de ces compositions thérapeutiques pour le traitement d'animaux.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)